Recent progress of treating acute myeloid leukemia in the elderly: reports from the 56th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2015.04.004
- VernacularTitle:老年人急性髓系白血病治疗新进展:第56届美国血液学会年会报道
- Author:
Liangming MA
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,acute;
Aged;
Treatment;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2015;24(4):203-207
- CountryChina
- Language:Chinese
-
Abstract:
Acute myeloid leukemia (AML) is a disease of the elderly.Treating acute myeloid leukemia in the elderly is the highlight in the 56th American Society of Hematology (ASH) annual meeting.The question of which elderly patients with AML benefit from conventional intensive chemotherapy versus hypomethylating therapy or novel agent remains uncertain.This article reviews the latest research presented at the 56th ASH annual meeting on the elderly AML.
